PHAXIAM Therapeutics S.A. Capital Reserve
PHAXIAM Therapeutics S.A. had Capital Reserve of -EUR 25.37 million as of 2020-06-30, per its 6-K filed 2020-09-21.
Discontinued › Notes
ifrs-full:CapitalReserve · last filed 2020-09-21
- 2020-06-30: Capital Reserve -25.37M EUR.
- 2019-12-31: Capital Reserve -136.61M EUR; Capital Reserve as first filed 136.61M EUR.
- 2019-06-30: Capital Reserve -137.25M EUR.
- 2018-12-31: Capital Reserve 99.52M EUR; Capital Reserve as first filed -99.52M EUR.
| Period end | Capital Reserve | Capital Reserve as first filed |
|---|---|---|
| 2020-06-30 | -25.37M EUR 6-K · filed 2020-09-21 | |
| 2019-12-31 | -136.61M EUR 6-K · filed 2020-09-21 | 136.61M EUR 20-F · filed 2020-03-18 |
| 2019-06-30 | -137.25M EUR 6-K · filed 2019-09-26 | |
| 2018-12-31 | 99.52M EUR 20-F · filed 2020-03-18 | -99.52M EUR 20-F · filed 2019-03-29 |
| 2017-12-31 | 68.39M EUR 20-F · filed 2020-03-18 | -68.39M EUR 20-F/A · filed 2018-05-23 |
| 2016-12-31 | -48.25M EUR 20-F · filed 2019-03-29 | |
| 2015-12-31 | -34.58M EUR 20-F/A · filed 2018-05-23 |